Page last updated: 2024-09-02

tryptoquivaline and Inflammation

tryptoquivaline has been researched along with Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, J; Pan, Z; Wang, C; Zhou, Y	1

Other Studies

1 other study(ies) available for tryptoquivaline and Inflammation

Article	Year
Fumitremorgin C alleviates advanced glycation end products (AGE)-induced chondrocyte inflammation and collagen II and aggrecan degradation through sirtuin-1 (SIRT1)/nuclear factor (NF)-κB/ mitogen-activated protein kinase (MAPK). Bioengineered, 2022, Volume: 13, Issue:2 Topics: Aggrecans; ATP Binding Cassette Transporter, Subfamily G, Member 2; Chondrocytes; Collagen; Glycation End Products, Advanced; Humans; Indoles; Inflammation; Mitogen-Activated Protein Kinases; Neoplasm Proteins; NF-kappa B; Osteoarthritis; Sirtuin 1	2022

Article

Year

Fumitremorgin C alleviates advanced glycation end products (AGE)-induced chondrocyte inflammation and collagen II and aggrecan degradation through sirtuin-1 (SIRT1)/nuclear factor (NF)-κB/ mitogen-activated protein kinase (MAPK).

Bioengineered, 2022, Volume: 13, Issue:2

Topics: Aggrecans; ATP Binding Cassette Transporter, Subfamily G, Member 2; Chondrocytes; Collagen; Glycation End Products, Advanced; Humans; Indoles; Inflammation; Mitogen-Activated Protein Kinases; Neoplasm Proteins; NF-kappa B; Osteoarthritis; Sirtuin 1

2022